# HMGB1 binds to and disrupts the hairpin structure of RNA15 and inhibits toll-like receptor activation

**Authors:** Cong Lin, Penghui Li, Anna G. Savitskaya, Ekaterina Lyukmanova, Sergey A. Goncharuk, Konstantin S. Mineev, Xiubo Du, Yibo Wang, Xiaohui Wang

PMC · DOI: 10.1016/j.jbc.2026.111155 · The Journal of Biological Chemistry · 2026-01-12

## TL;DR

This study shows that HMGB1 disrupts RNA15 structure, preventing TLR13 activation and reducing inflammation.

## Contribution

The paper introduces a novel mechanism where HMGB1 inhibits TLR13 signaling by altering RNA ligand structure.

## Key findings

- HMGB1 binds RNA15 with high affinity and disrupts its hairpin structure.
- HMGB1 binding leads to a stem-open RNA15 conformation, inhibiting TLR13 activation.
- HMGB1 reduces RNA15-induced inflammatory mediator production in a dose-dependent manner.

## Abstract

Toll-like receptor 13 (TLR13) is a critical innate immune sensor that recognizes a conserved RNA sequence, RNA15 (2054–2068, ACG GAA AGA CCC CGU), within bacterial 23S rRNA, thereby initiating a proinflammatory response. While the alarmin high mobility group box 1 (HMGB1) is known to modulate various TLR pathways, its influence on TLR13 signaling has remained unexplored. Here, we reveal that HMGB1 directly binds RNA15 with high affinity and profoundly disrupts its hairpin structure, which is essential for TLR13 recognition. Using a combination of fluorescence anisotropy, FRET assays, NMR spectroscopy, and enhanced-sampling molecular dynamics simulations, we demonstrate that HMGB1 binding remodels RNA15 into a stem-open conformation, making it thermodynamically unfavorable for receptor activation. Functionally, HMGB1 significantly inhibits RNA15-induced TLR13 activation, leading to a dose-dependent reduction in inflammatory mediators. These findings uncover a novel “ligand remodeling” mechanism, whereby HMGB1 acts as a negative regulator of TLR13 signaling by structurally altering the RNA ligand rather than directly blocking the receptor. This work provides new insights into host–pathogen interactions and suggests important implications for the design and immunogenicity of RNA-based therapeutics and vaccines.

## Linked entities

- **Genes:** Tlr13 (toll-like receptor 13) [NCBI Gene 279572], HMGB1 (high mobility group box 1) [NCBI Gene 3146]
- **Proteins:** HMGB1 (high mobility group box 1), Tlr13 (toll-like receptor 13)

## Full-text entities

- **Genes:** HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** Hairpin (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12887398/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12887398/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12887398/full.md

---
Source: https://tomesphere.com/paper/PMC12887398